High bax expression modulates response to treatment and survival in AML.

High bax expression modulates response to treatment and survival in AML.

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Truran, L, Kell, J, Nicholson, D, Harrison, G, Hoy, T, Burnett, A
Formáid:	Journal article
Foilsithe / Cruthaithe:	1999

Míreanna comhchosúla

Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis
de réir: Nadege Gitego, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Bim, Bak, and Bax regulate osteoblast survival.
de réir: Liang, M, et al.
Foilsithe / Cruthaithe: (2008)

THE CHALLENGE OF AML IN OLDER PATIENTS
de réir: Alan K Burnett
Foilsithe / Cruthaithe: (2013-06-01)

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.
de réir: Grimwade, D, et al.
Foilsithe / Cruthaithe: (1999)

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
de réir: Grimwade, D, et al.
Foilsithe / Cruthaithe: (1996)

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials.
de réir: Peniket, A, et al.
Foilsithe / Cruthaithe: (1999)

THE EFFECT OF UREA SUPLEMENTATION IN MATURATION MEDIA OF BOVINE OOCYTE IN VITRO TOWARDS EXPRESSION OF BAX, BCL-2 AND BAX/BCL-2 RATIO
de réir: Dhesy Kartikasari, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Leptin and curcumin affect renal ischemia-reperfusion injury via modulation of P65 and Bax genes expression
de réir: M. M. Ragy, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Regulation of HOX gene expression in AML
de réir: Irum Khan, et al.
Foilsithe / Cruthaithe: (2024-03-01)

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
de réir: Grimwade, D, et al.
Foilsithe / Cruthaithe: (2001)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
de réir: Grimwade, D, et al.
Foilsithe / Cruthaithe: (1998)

8-Hydroxydaidzein Induces Apoptosis and Inhibits AML-Associated Gene Expression in U-937 Cells: Potential Phytochemical for AML Treatment
de réir: Pei-Shan Wu, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Coenzyme Q10 Protects Hippocampal Neurons against Ischemia/ Reperfusion Injury via Modulation of BAX/Bcl-2 Expression
de réir: Mohammad Zamani, et al.
Foilsithe / Cruthaithe: (2012-09-01)

Coenzyme Q10 Protects Hippocampal Neurons Against Ischemia/Reperfusion Injury via Modulation of BAX/Bcl-2 Expression
de réir: M Zamani, et al.
Foilsithe / Cruthaithe: (2012-12-01)

Association between reproducible flow cytometric methodology for measuring multidrug resistance and remission rates in AML
de réir: Pallis, M, et al.
Foilsithe / Cruthaithe: (1998)

Investigation into the Effect of Aspartame on the Expression of p53 and BAX in Mouse Stomach Tissue
de réir: Angelique Cheryl, et al.
Foilsithe / Cruthaithe: (2024-12-01)

The Expression Pattern of Bcl-2 and Bax in the Tumor and Stromal Cells in Colorectal Carcinoma
de réir: Nenad Kunac, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Evaluation of Bax In situ hybridization and PCNA Immunohistochemical Expression in Adenoid Cystic Carcinoma
de réir: Lehadh Muhammed Al-Azzawi, et al.
Foilsithe / Cruthaithe: (2019-07-01)

Evaluation of Bax In situ hybridization and PCNA Immunohistochemical Expression in Adenoid Cystic Carcinoma
de réir: Lehadh Muhammed Al-Azzawi, et al.
Foilsithe / Cruthaithe: (2019-07-01)

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.
de réir: Kottaridis, P, et al.
Foilsithe / Cruthaithe: (2000)

The Evolving Treatment Landscape of AML
de réir: Sabine Blum, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Del (9q) AML: clinical and cytological characteristics and prognostic implications.
de réir: Peniket, A, et al.
Foilsithe / Cruthaithe: (2005)

Evolving racial/ethnic disparities in AML survival in the novel therapy era
de réir: Xin Wang, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression
de réir: Xihan Liu, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Expression of BAX and Bcl-2 gene in prostate carcinoma and its correlation with gleason score
de réir: Aiswarya Unnithan, et al.
Foilsithe / Cruthaithe: (2023-01-01)

An optimized protocol for expression and purification of monomeric full-length BAX protein for functional interrogations
de réir: Yiyang Chen, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Mechanisms of response and resistance to AML therapies
de réir: Stoilova, B, et al.
Foilsithe / Cruthaithe: (2020)

Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?
de réir: Hester F Lingsma, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Venetoclax for AML: changing the treatment paradigm
de réir: Daniel A. Pollyea, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Electro-acupuncture modulated miR-214 expression to prevent chondrocyte apoptosis and reduce pain by targeting BAX and TRPV4 in osteoarthritis rats
de réir: Jia He, et al.
Foilsithe / Cruthaithe: (2024-05-01)

PB1918: HIGH BAX/BCL-2 RATIO IS ASSOCIATED WITH GOOD PROGNOSIS AND BETTER SURVIVAL IN PATIENTS WITH B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
de réir: Nesrine Helaly
Foilsithe / Cruthaithe: (2023-08-01)

High-Resolution Pictures of AML Hierarchies
de réir: Melania Tesio
Foilsithe / Cruthaithe: (2019-06-01)

Expression profiling of snoRNAs in normal hematopoiesis and AML
de réir: Wayne A. Warner, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Expression of Apoptotic Proteins Bax and Bcl-2 in Blood Cells of Type 2 Diabetic Patients
de réir: Ebru Gokalp-Ozkorkmaz, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Modeling early treatment response in AML from cell-free tumor DNA
de réir: Dantong Wang, et al.
Foilsithe / Cruthaithe: (2023-12-01)

PB1821: THE INFLUENCE OF BCL2, BAX, BAX/BCL2 RATIO AND MDR1 GENE EXPRESSION ON PROGNOSIS OF ADULT DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE
de réir: Zlatko Pravdic, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Protective Effects of Nucleobinding-2 After Cerebral Ischemia Via Modulating Bcl-2/Bax Ratio and Reducing Glial Fibrillary Acid Protein Expression
de réir: Soheila Erfani, et al.
Foilsithe / Cruthaithe: (2019-09-01)

Gene expression profiling in MDS and AML: potential and future avenues.
de réir: Theilgaard-Mönch, K, et al.
Foilsithe / Cruthaithe: (2011)

Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively
de réir: Reinaldo Dal Bello, et al.
Foilsithe / Cruthaithe: (2023-01-01)

A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML10 trial.
de réir: Wheatley, K, et al.
Foilsithe / Cruthaithe: (1995)